Table 3.

Trends Over Time for Odds Ratio With 95% CI and P Values for Women to Receive Specific Treatment at Discharge

	β-Blocker	ACEI/ARB	ASA	P2Y12*	Statin	Nitrates
Per calendar year	1.01 (1.00 to 1.01)	0.98 (0.97 to 0.99)	0.99 (0.98 to 1.00)	1.03 (1.01 to 1.05)	0.94 (0.78 to 0.86)	1.09 (1.04 to 1.15)
	P=0.089	P<0.001	P=0.205	P=0.014	P<0.001	P=0.001
Over 5 years	1995–2000	1995–2000	1995–2000	N/A	1995–2000	1995–2000
	0.83 (0.74 to 0.92)	0.94 (0.86 to 1.09)	0.91 (0.82 to 1.02)		1.17 (1.03 to 1.33)	0.96 (0.86 to 1.06)
	2000–2005	2000–2005	2000–2005		2000–2005	2000–2005
	0.96 (0.87 to 1.05)	0.91 (0.84 to 0.98)	1.08 (0.99 to 1.18)		1.03 (0.95 to 1.12)	0.95 (0.87 to 1.04)
	2005–2010	2005–2010	2005–2010		2005–2010	2005–2010
	0.93 (0.84 to 1.03)	0.80 (0.75 to 0.87)	0.95 (0.86 to 1.05)		0.65 (0.60 to 0.72)	1.22 (1.11 to 1.35)
	2010–2014	2010–2014	2010–2014		2010–2014	2010–2013
	0.94 (0.84 to 1.05)	0.75 (0.69 to 0.82)	0.83 (0.73 to 0.94)		0.58 (0.51 to 0.64)	1.27 (1.14 to 1.42)
	P=0.191	P=0.001	P=0.005		P<0.001	P<0.001
Before and after 2005	Before 2005	Before 2005	Before 2005	N/A	Before 2005	Before 2005
	0.89 (0.83 to 0.96)	0.92 (0.87 to 0.98)	1.00 (0.94 to 1.08)		1.07 (1.00 to 1.15)	0.95 (0.89 to 1.02)
	After 2005	After 2005	After 2005		After 2005	After 2005
	0.93 (0.87 to 1.00)	0.78 (0.74 to 0.83)	0.90 (0.83 to 0.98)		0.62 (0.58 to 0.67)	1.24 (1.15 to 1.34)
	P=0.388	P<0.001	P=0.039		P<0.001	P<0.001

ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, acetylsalicylic acid; N/A, not available.

^*From 2005 to 2014.